Benzocaine hydrochloride 是一种表面麻醉剂，通过阻止脉冲沿神经纤维和神经末梢传递而起作用。

Benzocaine hydrochloride is a surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.

AZD7762, a more selective Chk1 inhibitor, inhibits Chk1 phosphorylation of a cdc25C peptide by reversibly binding to the ATP-binding site of Chk1, with IC50 of 5 nM and Ki of 3.6 nM. AZD7762 induces cell arrest with EC50 of 0.620 μM, and significantly abrogates the camptothecin induced G2 arrest with an EC50 of 10 nM, by blocking the chk1 dependent degradation of Cdc25A and activation of Cyclin A. AZD7762 (300 nM) enhances the antitumor efficacy of gemcitabine against SW620 and topotecan against MDA-MB-231 by reducing the GI50 values from 24.1 nM and 2.25 μM to 1.08 nM and 0.15 μM, respectively. [1] AZD7762 shows cytotoxicity against a variety of neuroblastoma cell lines bearing p53 wild type, p53 mutation, Mdm2 amplification or p14 deletion with IC50 values ranging from 82.6-505.9 nM. [2]

23239-88-5

C9H12ClNO2

201.65

Ethyl p-aminobenzoate hydrochloride;Ethyl 4-aminobenzoate hydrochloride;Benzocaine HCl;Benzocaine hydrochloride

DMSO:38 mg/mL (188.4 mM)
H2O:<1 mgml
Ethanol:38 mg/mL (188.4 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years